PPT-1171MO β PACIFIC-R Real-World Study:
Treatment Duration and Interim Analysis of ProgressionFree Survival in Unresectable Stage III NSCLC Patients Treated with Durvalumab After Chemoradiotherapy Disclosure
Download Presentation
"1171MO β PACIFIC-R Real-World Study:" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.